30
Participants
Start Date
May 15, 2017
Primary Completion Date
October 25, 2017
Study Completion Date
October 25, 2017
GLPG1972 cohort 1
GLPG1972 dose 1 provided as oral tablets q.d.
GLPG1972 cohort 2
GLPG1972 dose 2 provided as oral tablets q.d.
GLPG1972 cohort 3
GLPG1972 dose 3 provided as oral tablets q.d.
Placebo
Matching placebo provided as oral tablets q.d.
Covance Daytona Beach, Daytona Beach
Lead Sponsor
Galapagos NV
INDUSTRY